Literature DB >> 23290784

Innate immune processes in lupus erythematosus.

Martin Aringer1, Claudia Günther, Min Ae Lee-Kirsch.   

Abstract

The innate immune system is involved in the pathogenesis of systemic autoimmune diseases such as systemic lupus erythematosus (SLE) or dermatomyositis. The important role of complement factors of the classical pathway and of Toll like receptors (TLRs) is well established, based on genetic and clinical evidence. Immune complexes activate tumor necrosis factor (TNF) in myeloid cells and interferon-α (IFNα) in plasmacytoid dendritic cells. The latter initiates a positive feedback loop that drives autoimmunity. More recently, mutations in genes encoding intracellular enzymes involved in RNA and DNA handling, which likewise lead to increased IFNα, have been found to cause familial chilblain lupus and to be associated with SLE. Within the immunological disease continuum, these disorders can be placed between autoinflammation and autoimmunity, and we would propose the term autoadjuvant for this group, since the activation of the innate immune system in these diseases appears to lower the threshold for (auto)immune reactions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23290784     DOI: 10.1016/j.clim.2012.11.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  17 in total

Review 1.  Post-transcriptional regulation of gene expression in innate immunity.

Authors:  Susan Carpenter; Emiliano P Ricci; Blandine C Mercier; Melissa J Moore; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

Review 2.  Transcription of inflammatory genes: long noncoding RNA and beyond.

Authors:  Susan Carpenter; Katherine A Fitzgerald
Journal:  J Interferon Cytokine Res       Date:  2014-09-24       Impact factor: 2.607

Review 3.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

4.  Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.

Authors:  Paul Alves; Muhammad M Bashir; Maria Wysocka; Majid Zeidi; Rui Feng; Victoria P Werth
Journal:  J Investig Dermatol Symp Proc       Date:  2017-10

Review 5.  Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Authors:  Trisha A Rettig; Julie N Harbin; Adelaide Harrington; Leonie Dohmen; Sherry D Fleming
Journal:  Clin Immunol       Date:  2015-07-02       Impact factor: 3.969

6.  Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus.

Authors:  Nicholas A Young; Giancarlo R Valiente; Jeffrey M Hampton; Lai-Chu Wu; Craig J Burd; William L Willis; Michael Bruss; Holly Steigelman; Maya Gotsatsenko; Stephanie A Amici; Mary Severin; Lucila Marino Claverie; Mireia Guerau-de-Arellano; Amy Lovett-Racke; Stacy Ardoin; Wael N Jarjour
Journal:  Clin Immunol       Date:  2016-12-27       Impact factor: 3.969

Review 7.  UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?

Authors:  Ji-Hong Cui; Xin Xie
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 8.  Rheumatologic manifestations of primary immunodeficiency diseases.

Authors:  V R Dimitriades; R Sorensen
Journal:  Clin Rheumatol       Date:  2016-03-14       Impact factor: 2.980

Review 9.  Mechanisms of tissue damage in arthritis.

Authors:  Stephan Blüml; Kurt Redlich; Josef S Smolen
Journal:  Semin Immunopathol       Date:  2014-09-12       Impact factor: 9.623

Review 10.  Unmet needs in autoimmunity and potential new tools.

Authors:  Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.